한국어
English
日本語
中文(简体)
Tykerb Tablets 250 Milligrams (Lapatinib Ditosilate)
405mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Lapatinib ditosylate is an anticancer drug component used for the treatment of HER2-positive cancer.
MFDS ingredient code M215173
Lapatinib ditosylate is a targeted therapy anticancer drug primarily used to attack cancer cells overexpressing the HER2 protein. This component belongs to the class of tyrosine kinase inhibitors and plays a role in blocking the growth signaling in cancer cells.
Lapatinib inhibits the tyrosine kinase activity of the HER2 receptors and EGFR receptors on the surface of cancer cells, preventing cell proliferation. This action delays the progression of cancer by inhibiting the growth and division processes of cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other HER2 targeted therapies, Lapatinib can be taken orally and is characterized by its dual action in simultaneously inhibiting EGFR and HER2. This makes it an effective treatment option for certain HER2-positive cancers.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.